Neutral Displacement Needleless Connectors Market Global Report 2026

The neutral displacement needleless connectors market size has grown strongly in recent years. It will grow from $0.8 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising incidence of catheter-related bloodstream infections, increasing adoption of intravenous drug delivery systems, development of early needleless access technologies, growth in hospital infection control protocols, increasing awareness of healthcare associated infection risks.

The neutral displacement needleless connectors market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expansion of hospital infrastructure and critical care units, rising demand for home-based intravenous therapy, increasing regulatory standards for infection prevention in iv systems, growth in chronic disease treatments requiring long term iv access, technological advancement in anti-reflux valve connector systems. Major trends in the forecast period include expansion of closed system iv access solutions for infection prevention, increasing adoption of anti-reflux connector technologies to reduce catheter complications, development of needleless iv systems for enhanced healthcare worker safety, rising demand for single-use sterile iv connectors in hospital settings, integration of advanced valve-based mechanisms for improved iv flow control and safety.

The increasing incidence of hospital-acquired infections is expected to propel the growth of the neutral displacement needleless connectors market going forward. Hospital-acquired infections are infections that patients develop during their stay in a hospital or healthcare facility that were not present or incubating at the time of admission. Hospital-acquired infections are increasing mainly due to the increasing use of invasive devices such as catheters and ventilators, which can allow germs to enter the body if not properly sterilized or managed. Neutral displacement needleless connectors help reduce hospital-acquired infections by preventing blood reflux into IV lines when access devices are disconnected, thereby lowering the risk of microbial contamination and bloodstream infections. For instance, in January 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, there was approximately a 4% increase in the standardized infection ratio (SIR) for surgical site infections (SSI) across all NHSN operative procedure categories combined compared to the previous year. Therefore, the increasing incidence of hospital-acquired infections is expected to propel the growth of the neutral displacement needleless connectors market.

The growth in surgical procedures is expected to propel the growth of the neutral displacement needleless connectors market going forward. Surgical procedures are medical operations performed by healthcare professionals where they use instruments to repair, remove, or replace diseased or damaged tissues or organs in the body. Surgical procedures are increasing mainly due to the rising prevalence of chronic diseases such as heart disease, cancer, and orthopedic disorders that often require surgical intervention. Neutral displacement needleless connectors help in surgical procedures by maintaining IV line sterility and preventing backflow of blood into the catheter, which reduces the risk of catheter-related bloodstream infections and ensures safe and reliable drug and fluid administration during and after surgery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, in 2023, liposuction continued to be the most sought-after plastic surgery procedure, with nearly 350,000 procedures carried out, marking a 7% increase compared to 2022. Therefore, the growth in surgical procedures is driving the growth of the neutral displacement needleless connectors market.

Key operating in the neutral displacement needleless connectors market are focusing on developing advanced solutions, such as drug-resistant needleless connectors, to enhance compatibility with a wide range of medications and improve patient safety. Drug-resistant needleless connectors are IV access devices engineered with materials that prevent chemical interaction, adsorption, or degradation from various medications, ensuring drug stability and safe, contamination-free fluid transfer while reducing risks of connector damage or dosing inconsistencies. For example, in December 2023, B. Braun, a Germany-based medical technology company, launched the CARESITE Micro Luer Access Device and Extension Sets, which feature a compact micro Luer design for easier handling and integration into IV systems and support drug-resistant needleless access to help reduce needlestick injuries among healthcare professionals. The devices are designed to maintain a closed IV system, minimizing contamination and infection risk, and are compatible with extension sets to improve flexibility in infusion therapy setups. They also facilitate safe and efficient drug administration and fluid management in clinical settings.

Major companies operating in the neutral displacement needleless connectors market are Cardinal Health Inc., Lily Medical Corporation, Medline Industries LP, Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Teleflex Incorporated, ICU Medical Inc., Merit Medical Systems Inc., Adler Medical Systems LLC, Vygon SAS, Vygon Group, Qosina Corporation, Poly Medicure Limited, Dynarex Corporation, MedSource Labs LLC, GBUK Group Limited, NP Medical Inc., RyMed Technologies LLC.

North America was the largest region in the neutral displacement needleless connectors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neutral displacement needleless connectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neutral displacement needleless connectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neutral displacement needleless connectors market consists of sales of Luer-activated valve connectors, split septum connectors, and bidirectional connectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.